维普中文期刊产品整合服务
82篇 您的检索式:作者名="Mohammad V"
    题名 作者 年代 出处 被引量
1Vascular endothelial growth factor trap-eye(Aflibercept) for the management of diabetic macular edema显示文摘Diabetic retinopathy(DR)is the most common cause of visual loss among working age individuals.Diabetic macular edema(DME)is an important complication of DR that affects around one third of the patients with DR.Several treatments have been approved for DME ranging from blood pressure and glycemic control to photocoagulation and more recently the use of vascular endothelial growth factor(VEGF)antagonists.The index review discusses aflibercept(EYLEA-Regeneron Pharmaceuticals,Inc.,Tarrytown,New York,NY,and Bayer Healthcare Pharmaceuticals,Berlin,Germany)in the context of other VEGF antagonists currently available for the treatment of DME.A systematic search of literature was conducted on PubMed,Scopus,and Google Scholar with no limitation on language or year of publication.Pre-clinical studies of aflibercept have shown a higher affinity of this molecule for vascular endothelial growth factor A(VEGF-A)along with a longer duration of action as compared to other VEGF antagonists.Recent clinical trials have shown visual outcome results for aflibercept to be similarly favorable as compared to other available agents with the added benefit of fewer required injections and less frequent monitoring.Aflibercept presents a potential exciting new addition to the armamentarium of current VEGF antagonists available for the treatment of DME and other retinal vascular diseases.However,further studies are indicated to confirm the role,safety,and efficacy of aflibercept for DME.Ahmadreza Moradi Yasir Jamal Sepah Mohammad Ali Sadiq Humzah Nasir Salima Kherani Raafay Sophie Diana V Do Quan Dong Nguyen 2013World Journal of Diabetes2013,4,6:8
2Mortality Associated With Atrial Fibrillation in Patients With Myocardial Infarction: A Systematic Review and Meta-Analysis显示文摘Patricia Jabre Véronique L. Roger Mohammad H. Murad Alanna M. Chamberlain Larry Prokop Frédéric Adnet Xavier Jouven 2011Circulation2011,,15:2
3Trends in treatment and overall survival among patients with proximal esophageal cancer显示文摘BACKGROUND The management of proximal esophageal cancer differs from that of tumors located in the mid and lower part of the esophagus due to the close vicinity of vital structures.Non-surgical treatment options like radiotherapy and definitive chemoradiation(CRT)have been implemented.The trends in(non-)surgical treatment and its impact on overall survival(OS)in patients with proximal esophageal cancer are unclear,related to its rare disease status.To optimize treatment strategies and counseling of patients with proximal esophageal cancer,it is therefore essential to gain more insight through real-life studies.AIM To establish trends in treatment and OS in patients with proximal esophageal cancer.METHODS In this population-based study,patients with proximal esophageal cancer diagnosed between 1989 and 2014 were identified in the Netherlands Cancer Registry.The proximal esophagus consists of the cervical esophagus and the upper thoracic section,extending to 24 cm from the incisors.Trends in radiotherapy,chemotherapy,and surgery,and OS were assessed.Analyses were stratified by presence of distant metastasis.Multivariable Cox proportional hazards regression analyses was performed to assess the effect of period of diagnosis on OS,adjusted for patient,tumor,and treatment characteristics.RESULTS In total,2783 patients were included.Over the study period,the use of radiotherapy,resection,and CRT in non-metastatic disease changed from 53%,23%,and 1%in 1989-1994 to 21%,9%,and 49%in 2010-2014,respectively.In metastatic disease,the use of chemotherapy and radiotherapy increased over time.Median OS of the total population increased from 7.3 mo[95%confidence interval(CI):6.4-8.1]in 1989-1994 to 9.5 mo(95%CI:8.1-10.8)in 2010-2014(logrank P<0.001).In non-metastatic disease,5-year OS rates improved from 5%(95%CI:3%-7%)in 1989-1994 to 13%(95%CI:9%-17%)in 2010-2014(logrank P<0.001).Multivariable regression analysis demonstrated a significant treatment effect over time on survival.In metastatic disease,median OS was 3.8 mo(95%CI:2.5-5.1)in 1989-1994,and 5.1 mo(95%CI:4.3-5.9)in 2010-2014(logrank P=0.26).CONCLUSION OS significantly improved in non-metastatic proximal esophageal cancer,likely to be associated with an increased use of CRT.Patterns in metastatic disease did not change significantly over time.Judith de Vos-Geelen Sandra ME Geurts Liselot BJ Valkenburg-van Iersel Evelien JM de Jong Vivianne CG Tjan-Heijnen Margreet van Putten Valery EPP Lemmens Heike I Grabsch Nadia Haj Mohammad Frank JP Hoebers Chantal V Hoge Paul M Jeene Hanneke WM van Laarhoven Tom Rozema Marije Slingerland Grard AP Nieuwenhuijzen 2019World Journal of Gastroenterology2019,25,47:2
4Performance analysis of bearing-only tracking algorithm 显示文摘DAVID V HUY S MOHAMMAD F 2004Proceedings of SHE2004,3365,7:1
5Nepehinol-a new triterpene from Nepeta hindostana显示文摘Ahmad V U Bano S Mohammad F V 1985Planta Med1985,,6:1
6Temporal bone disease:a comparison between high resolution computed tomography and pluridirectional tomography显示文摘Chat V Mohammad S Leon K 1983Radiology1983,147,:1
7Influenza vaccination: an emerging opportunity to prevent cardio vascular disease显示文摘Mohammad M Silvio L Deborah V 2004International Congress Series2004,126,3:1
8Vanadium increases GLUT4 in diabetic rat skeletal muscle显示文摘MOHAMMAD A SHARMA V MCNEILL J H 2002Mol Cell Biochem2002,233,12:1
9Performance analysis of bearing only tracking algorithm显示文摘DAVID V HUY S MOHAMMAD F 2004Proceedings of SPIE2004,3365,7:1
10Development of azithromycin-PLGA nanoparticles:Physicochemical characterization and antibacterial effect against Salmonella typhi显示文摘Ghobad M Hadi V Mohammad B J 2010Colloid Surface B2010,80,:1
11Pyrrolizidine Alkaloids from Senecio Lorenthii显示文摘Noorwala M Mohammad F V Ahmad V U 2000Fitoterapia2000,71,5:1
12Outpatient laparosco- pie adrenaleetomy: a Canadian experience 显示文摘Mohammad WM Frost I Moonje V 2009Surg Lapa- rosc Endosc Pereutan Tech2009,,4:1
13Incidence of Upper Limb Venous Thronbosis Associated with Peripherally Inserted Central Catheters (PICC)显示文摘Abdullah B J Mohammad N Sangkar J V 2005Br J Radiol2005,78,931:1
14Antidiabetic effects of quercetin in streptozotocin-induced diabetic rats显示文摘Mahmood V Mina H Mohammad V 2003Comp Biochem Physiol P2003,135,3:1
15Effects of Fusion Zone Size and Failure Mode on Peak Load and Energy Absorption of Advanced High Strength Steel Spot Welds Under Lap Shear Loading Conditions 显示文摘Xin Sun Elizabeth V Stephens Mohammad A Khaleel 2008Engineering Failure Analysis2008,15,:1
16Quantum dots:synthesis,bioapplications and toxicity显示文摘Alireza V Haleh M Mohammad S 2012Nanosale Res Left2012,7,1:1
17Influenza vaccination:an emerging opportunity to prevent cardio vascular disease显示文摘Mohammad M Silvio L Deborah V 2004International Congress Series2004,126,3:1
18Modeling TCP long file transfer latency over long delay wireless multilink PPP 显示文摘ZAGHLOUL S FROST V MOHAMMAD A J 2005Communications Letters2005,9,11:1
19Sorption of arsenic,cadmium,and lead by chars produced from fast pyrolysis of wood and bark during bio-oil production显示文摘Mohan D Pittman C.U Bricka M Smith F Yancey B Mohammad J Steele P.H Alexandre-Franco M.F Gómez-Serrano V Gong H 0,,01:1
20Outpatient laparoscopic adrenalectomy:a Canadian experience显示文摘MOHAMMAD WM FROST I MOONJE V 2009Surg Laparosc Endosc Percutan Tech2009,19,4:1
返回顶部 每页显示:
共5页 首页 上一页 第1页 下一页 末页 /5 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费